| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 20, 2014
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that it is commencing a registered public offering of...
-
Nov 6, 2014
Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has reinitiated shipments of Guaifenesin 600mg Extended-Release tablets to its retail and wholesale customers in the United States....
-
Nov 6, 2014
Fiscal first quarter net sales increased to a first quarter record of $952 million. Fiscal first quarter adjusted net income increased 30% to a first quarter record of $188 million, with reported...
-
Nov 6, 2014- Accelerates Perrigo's stated strategy to expand internationally and leverage its existing product portfolio
Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," and Omega Pharma NV, one of the largest OTC healthcare companies in Europe,...
-
Nov 3, 2014
Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on December 16, 2014 to shareholders of record on...
-
Oct 23, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its first quarter fiscal year 2015 on Thursday, November 6, 2014 at approximately 8:00 a.m. (ET)....
-
Oct 14, 2014
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), is proud to announce that its Kansas City, Kansas, manufacturing facility has obtained Safety Quality Food (SQF) Code...
-
Oct 2, 2014
Perrigo Company plc (NYSE: PRGO; TASE), a public limited company incorporated under the laws of Ireland (the "Company"), today announced the expiration of its offer to exchange (the "Exchange...
-
Oct 1, 2014
Perrigo Company plc (NYSE: PRGO; TASE), a public limited company incorporated under the laws of Ireland (the "Company"), today announced the extension of its offer to exchange (the "Exchange...
-
Sep 29, 2014
Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has transferred a portfolio of preclinical research assets, which it acquired through its December 2013 acquisition of Elan...